A to Z

LSU

Featured Neuroscience Open Neuroscience Articles

·March 23, 2020·2 min read

ACE inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19

Researchers confirm ACE inhibitors and ARBS medications may increase the risk of patients with COVID-19 developing more severe symptoms.

Image shows fish made out of omega 3 fish oil pills.

Featured Neurology

·July 18, 2017·4 min read

Could Omega 3 Fatty Acids Help Treat Alzheimer’s?

Researchers shed new light on how DHA, a key essential Omega-3 fatty acid, could help promote cell survival and contribute to treating Alzheimer's, Parkinson's disease and stoke.

This shows a diagram from the study and neurons

Featured Neurology Neuroscience Open Neuroscience Articles

·August 9, 2022·4 min read

Discovering a Major Contributor to Alzheimer’s Disease

Researchers identified a pathway that begins in the gut and ends with a pro-inflammatory protein in the brain that appears to contribute to the development and progression of Alzheimer's disease.

This shows a model of a head and a brain

Featured Neurology Neuroscience Open Neuroscience Articles

·March 21, 2022·3 min read

Intranasal Drug Halts Memory Decay in Experimental Alzheimer’s Model

Intranasal delivery of biologically active lipid messengers halts memory loss and neurodegeneration in mouse models of Alzheimer's disease.

Featured Neurology Open Neuroscience Articles

·August 7, 2020·4 min read

Key to Dialogue Between Brain Cells to Protect Against Stroke Discovered

DHA treatment reduced the size of the damaged brain area and initiated a repair mechanism in animal models of stroke. DHA affected the levels of MANF and TREM2, two proteins critical for communication between brain cells.

Featured Genetics Neuroscience Open Neuroscience Articles Visual Neuroscience

·July 12, 2022·3 min read

New Human Cell Line Developed to Study Blinding Eye Disorders

Researchers have developed a new experimental human cell line from retinal pigment epithelial cells, dubbed ABC cells, that can assist with the study of blinding eye diseases, including age-related macular degeneration.

Featured Neuroscience Open Neuroscience Articles Psychology

·December 17, 2020·2 min read

New Mechanism to Balance Emotional Behavior

GABA accelerates the breakdown of endocannabinoids in the brain. Endocannabinoids are critical for emotional processing. The findings could lead to the development of new treatments for emotional behavioral disorders.

Brain Cancer Featured Neurology Neuroscience Open Neuroscience Articles

·October 2, 2021·5 min read

New Treatment Combination Inhibits Glioblastoma Growth

A combination of approved and novel therapeutics improved survival rates and reduced both tumor volume and growth for those suffering from glioblastoma brain cancer.

Featured Neuroscience Open Neuroscience Articles

·July 14, 2017·5 min read

Newly Discovered Elovanoids Called a ‘Transformative New Concept of Biology’

Researchers report they have discovers a new class of mediators, named elovanoids. These bioactive chemical messengers are created from omega-3 very long chain polyunsaturated fatty acid and released in response to cell injury. The findings are reported in Scientific Reports.

Featured Genetics Neuroscience Open Neuroscience Articles Visual Neuroscience

·September 11, 2020·4 min read

Nonharmful Stress Protects Against Disease in Offspring

Researchers conduct the first study to use nonharmful stress, like intermittent systemic hypoxia, to protect against disease in the first generation offspring in mice.

This shows a dopamine stick and ball model

Featured Neuroscience Open Neuroscience Articles Psychology

·July 20, 2019·3 min read

Pioneering new study on dopamine and stress

A neuroimaging study on house sparrows reveals changes in the dopaminergic system could be a physiological mechanism underlying the negative behavioral effects of chronic stress. The findings shed light on stress and resilience in wildlife and humans.

This shows a brain surrounded by lightening bolts

Featured Neurology Neuroscience

·December 30, 2020·5 min read

Potential New Treatment Strategy for Stroke

Treatment with LAU-0901, a synthetic molecule that blocks pro-inflammatory platelet-activating factor, in addition to aspirin-triggered NPD1, reduced the size of damage areas in the brain, initiated repair mechanisms, and improved behavioral recovery following ischemic stroke.